Anxiety, Birth Weight, Postpartum Depression, Preterm Birth, Small for Gestational Age at Delivery
Conditions
Keywords
anxiety, depression, birth outcomes
Brief summary
In the proposed study the investigators will develop an early prenatal preventive intervention targeting anxiety and conduct a randomized controlled trial in Pakistan to test its efficacy in reducing generalized anxiety disorder and major depression in mothers in late pregnancy and the postnatal period. Investigators will evaluate the impact of the intervention on fetal and infant growth restriction as well as examine how the impact of the intervention is mediated (to elucidate mechanisms) and/or modified (to help optimize future adaptations of the program) by various social factors. A cost-effectiveness evaluation will shed light on the costs and benefits of intervention components in relation to outcomes, enabling policy-makers and public health planners to scale up this intervention according to resource budgeting requirements.
Detailed description
Common mental disorders (CMDs) such as anxiety and depression occur frequently in pregnancy and the postnatal period in lower- and middle income countries (LMICs). Prenatal anxiety, both subthreshold and clinical, adversely affects maternal wellbeing and outcomes among offspring, and is a major predictor of subsequent depression. Preventive approaches have enormous potential to reduce the negative effects of postnatal mental disorders in mothers and improve child outcomes. The study team proposes to create a scalable and sustainable early prevention intervention focusing on anxiety symptoms in pregnant women, to be delivered by non-specialist providers (Aim 1). The investigators will evaluate this preventive intervention through a trial by randomizing 1200 pregnant women from a public hospital in Islamabad Pakistan to either our Cognitive Behavioral Therapy-based (CBT-based) early-in-pregnancy program or to usual care. The investigators will study the effects of the intervention on 1) CMDs in the 3rd trimester of pregnancy and at 6 weeks postpartum (Aim 2) and on 2) fetal and newborn small-for-gestational age (SGA) outcomes (Aim 3). The investigators will also examine if interpersonal violence, perceived stress and social support mediate and/or modify the intervention effects on CMDs and perinatal outcomes (Aim 4). Finally, the investigators will conduct a cost-effectiveness evaluation, comparing costs and healthcare utilization for women in the prenatal intervention and enhanced usual care groups (Aim 5). Focusing on anxiety reduction is a major innovation; anxiety has not been addressed within prenatal intervention packages in LMICs, despite its association with increased postpartum depression and suboptimal fetal and infant outcomes. Pakistan has high prevalence of both women with prenatal anxiety (35% to 49%) and SGA newborns (\ 47%), providing an ideal research opportunity. The CBT-based approach, appropriate given its indication for anxiety and depression, is grounded in preliminary work in this population, where the investigators have previously successfully reduced postpartum depression. Intervening early in pregnancy is a further innovation that is critical for building the evidence base for preventative approaches to reduce maternal CMDs and related perinatal outcomes. The proposed mediation and effect modification analyses will improve understanding of mechanism(s) of action and help identify subpopulations for programmatic targeting. The use of non-specialized providers and integration within the primary care environment will guide scale up, while incorporating a cost-effectiveness analysis will aid policy-makers in resource allocation decisions. This study will inform the integration of preventive strategies that target anxiety with existing approaches for treatment of perinatal depression to further the evidence-base for transdiagnostic mental health initiatives globally, and will inform policies to support lifelong maternal mental health and resilience across generations
Interventions
Happy Mother Healthy Baby (HMHB) is a CBT-based psychosocial intervention for expectant women experiencing anxiety during their pregnancy. Strategies such as empathetic listening, thought challenging, behavior activation, problem management, take-home exercises, and family involvement are employed by HMHB.
Sponsors
Study design
Masking description
To maintain masking during the trial, intervention and assessment teams will not have any interaction during the trial, as they will be placed at separate locations within the Obstetrics Department of Holy Family Hospital (HFH). Furthermore, participants will be instructed not to disclose which type of treatment they are receiving to the assessment team. Fidelity of masking will be measured by having assessors guess the trial arm of each participant at the end of follow-up assessment. We hypothesize that assessors will only be able to correctly guess the condition of participants at a chance rate of nearly 50% at follow-up assessments, indicating that masking is maintained.
Intervention model description
Women with at least mild anxiety but not depression will be enrolled simultaneously into an intervention or an enhanced usual care group during pregnancy. Women in the intervention group will receive individual-based cognitive behavioral therapy. Women in the control group with receive enhanced usual care.
Eligibility
Inclusion criteria
1. ability to understand spoken Urdu 2. pregnant, ≤22 weeks' gestation 3. age ≥18 years 4. residence ≤20 km of Holy Family Hospital 5. intent to reside in the study areas until the completion of the study 6. score ≥8 for anxiety on the Hospital Anxiety and Depression Scale (HADS)
Exclusion criteria
1. Current major a depressive episode (MDE on SCID) or life-threatening health conditions including e.g. active severe depression or suicidal ideation 2. Self-report of past or current significant learning disability 3. Self-report of past or current psychiatric disorder (e.g. bipolar disorder or schizophrenia) or psychiatric care (e.g. current use of anxiolytic drug and/or other psychotropic drug) 4. medical disorders or severe maternal morbidity that require inpatient management that would preclude participation (101) 5. ICU admission indicated by diagnosis (not only for assessment)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of Participants With Combined Common Mental Disorders (CMDs, i.e. Anxiety and Depression). | 6 weeks postpartum | Data reported is the number of participants with Common Mental Disorders (CMDs), which is defined as a woman having either high anxiety or clinical depression at the time of follow-up. Both CMDs, anxiety was indicated by moderate to severe symptoms on the anxiety portion of the Hospital and Anxiety Scale (HADS). A cutoff of \>10 was used as the threshold for moderate to severe levels of anxiety. A Major Depressive Episode (MDE) was measured with the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders (SCID), which is a semi-structured interview used to make major Axis I Diagnostic and Statistical Manual of Mental Disorders (DSM) diagnoses. Its scoring will be based on case or non-case basis. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Number of Preterm Births | at birth | Number of infants born with \<37 weeks' gestation |
| Small-for-gestational Age Birth | at birth | \<10th% for gestational age at birth compared to the reference population |
| Low Birthweight | at birth | weight of ≤2500 grams |
Countries
Pakistan
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| Cognitive Behavioral Therapy Intervention for Anxiety Pregnant women experiencing anxiety randomized to the Happy Mother Healthy Baby (HMHB) intervention receive a CBT-based psychosocial intervention (with six core and up to six booster sessions). HMHB is a facility-based intervention delivered by non-specialist providers. It is aimed to raise psychosocial awareness and facilitate positive change inter personal wellbeing, social support, and bonding with their baby during pregnancy. It addresses with relapse prevention, planning for the baby's arrival, and in management of emotional challenges in the early postnatal period. Family member/s will be invited to attend 3 core sessions.
Cognitive Behavioral Therapy Intervention for Anxiety: Happy Mother Healthy Baby (HMHB) is a CBT-based psychosocial intervention for expectant women experiencing anxiety during their pregnancy. Strategies such as empathetic listening, thought challenging, behavior activation, problem management, take-home exercises, and family involvement are employed by HMHB. | 600 |
| Enhanced Usual Care Women randomized to the control group will receive enhanced usual care (EUC). The World Health Organization (WHO) recommends 8 antenatal visits for a positive pregnancy experience, the number of visits our EUC control group participants will receive (depending on their gestational week). Usual care will also be enhanced by hospital staff receiving additional training in mental health treatment and counseling. Transportation will be facilitated to assist participants in attending appointments and medically indicated ultrasounds will be paid for (as in the intervention group). | 600 |
| Total | 1,200 |
Baseline characteristics
| Characteristic | Cognitive Behavioral Therapy Intervention for Anxiety | Enhanced Usual Care | Total |
|---|---|---|---|
| Age, Continuous | 25.08 Years | 25.46 Years | 25.3 Years |
| Baseline Hospital Anxiety and Depression Score (HADS) of >=8 on the anxiety subscale | 600 participants | 600 participants | 1200 participants |
| Race (NIH/OMB) American Indian or Alaska Native | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Asian | 600 Participants | 600 Participants | 1200 Participants |
| Race (NIH/OMB) Black or African American | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) More than one race | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) White | 0 Participants | 0 Participants | 0 Participants |
| Region of Enrollment Pakistan | 600 Participants | 600 Participants | 1200 Participants |
| Sex: Female, Male Female | 600 Participants | 600 Participants | 1200 Participants |
| Sex: Female, Male Male | 0 Participants | 0 Participants | 0 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 0 / 600 | 0 / 600 |
| other Total, other adverse events | 0 / 600 | 0 / 600 |
| serious Total, serious adverse events | 48 / 600 | 42 / 600 |
Outcome results
Number of Participants With Combined Common Mental Disorders (CMDs, i.e. Anxiety and Depression).
Data reported is the number of participants with Common Mental Disorders (CMDs), which is defined as a woman having either high anxiety or clinical depression at the time of follow-up. Both CMDs, anxiety was indicated by moderate to severe symptoms on the anxiety portion of the Hospital and Anxiety Scale (HADS). A cutoff of \>10 was used as the threshold for moderate to severe levels of anxiety. A Major Depressive Episode (MDE) was measured with the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders (SCID), which is a semi-structured interview used to make major Axis I Diagnostic and Statistical Manual of Mental Disorders (DSM) diagnoses. Its scoring will be based on case or non-case basis.
Time frame: 6 weeks postpartum
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| Cognitive Behavioral Therapy Intervention for Anxiety | Number of Participants With Combined Common Mental Disorders (CMDs, i.e. Anxiety and Depression). | 57 Participants |
| Enhanced Usual Care | Number of Participants With Combined Common Mental Disorders (CMDs, i.e. Anxiety and Depression). | 178 Participants |
Low Birthweight
weight of ≤2500 grams
Time frame: at birth
Population: The analysis for the secondary outcomes on children is 720 rather than 755 for the primary outcome on mothers. The reason for this is because the sample size differed for these two groups for a number of reasons (e.g. women who did not carry their pregnancies to term).
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Cognitive Behavioral Therapy Intervention for Anxiety | Low Birthweight | 46 infants |
| Enhanced Usual Care | Low Birthweight | 53 infants |
Number of Preterm Births
Number of infants born with \<37 weeks' gestation
Time frame: at birth
Population: The analysis for the secondary outcomes on children is 720 rather than 755 for the primary outcome on mothers. The reason for this is because the sample size differed for these two groups for a number of reasons (e.g. women who did not carry their pregnancies to term).
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Cognitive Behavioral Therapy Intervention for Anxiety | Number of Preterm Births | 79 infants |
| Enhanced Usual Care | Number of Preterm Births | 68 infants |
Small-for-gestational Age Birth
\<10th% for gestational age at birth compared to the reference population
Time frame: at birth
Population: The analysis for the secondary outcomes on children is 720 rather than 755 for the primary outcome on mothers. The reason for this is because the sample size differed for these two groups for a number of reasons (e.g. women who did not carry their pregnancies to term).
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Cognitive Behavioral Therapy Intervention for Anxiety | Small-for-gestational Age Birth | 89 infants |
| Enhanced Usual Care | Small-for-gestational Age Birth | 105 infants |